Abstract:
A composition comprising gallocatechin gallate(GCG) is provided to increase expression of cholesterol 7alpha-hydroxylase and expression of a low density lipoprotein receptor(LDLR) and show better binding increase efficacy between a low density lipoprotein(LDL) and the LDLR than that of epigallocatechin gallate(EGCG), thereby showing excellent hyperlipidemia improving effect. A composition for improving hyperlipidemia comprises GCG as an effective ingredient, active ingredient, wherein the GCG is derived from green tea. A food or a pharmaceutical formulation comprises the composition for improving hyperlipidemia. Further, the composition for improving hyperlipidemia reduces a number of tyighlycerides in blood and increases a high density lipoprotein.
Abstract:
A cosmetic composition is provided to inhibit the amount of sebum produced from sebocytes by inhibiting the formation and activity of SREBP-1(Sterol Regulatory Element Binding Protein-1), thereby capable of effectively improving sebum metabolism and acne. A cosmetic composition comprises 0.001-30 wt.% of at least one selected from the group consisting of catechin such as epigallocatechin gallate(EGCG), gallocatechin gallate(GCG) and a mixture thereof and flavonols such as quercetin, kaempferol and myricetin as effective ingredients and is characterized in that it inhibit the formation and activity of SREBP-1 which is a transcription factor.
Abstract:
A skin external composition is provided to inhibit TNF-alpha(Tumor Necrosis Factor-alpha) and the expression of MMP-1 through activation of PPAR-alpha(Peroxisome Proliferator Activated Receptor-alpha), thereby inhibiting skin aging. A skin external composition comprises 0.001-10 wt.% of at least one kind selected from the group consisting of epigallocatechin(EGCG), gallocatechingallate(GCG), epicatechin gallate(ECG), catechin gallate(CG), catechin(C), gallic acid, quercetin, kaempferol, theobromine, theophylline, theanine, quinic acid, an ethanol extract of green tea leaves, an aqueous extract of green tea leaves, an extract of catechin 1 including 70% of catechin and an extract of catechin 2 including 50% of EGCG as an effective ingredient.
Abstract:
A skin external composition comprising optimal concentration of catechins and theanine is provided to increase biosynthesis of collagen in the inner skin, restore elasticity of the skin, and improve wrinkles in the skin by containing low concentration of catechins and theanine at a fixed ingredient rate. The skin external composition for promoting biosynthesis of collagen and improving skin aging and elasticity comprises 0.0004-0.025 wt.% of catechins and 0.008-2.5 wt.% of theanine based on the total weight of the composition, wherein the weight ratio of catechins to theanine is 1:20 to 1:100, and the catechin is EGCG(epigallocatechin gallate), GCG(gallocatechin gallate), ECG(epicatechin gallate) or CG(catechin gallate).
Abstract:
PURPOSE: Provided is a composition for inhibiting phagocytosis containing Saururus Chinesis(Lour) Bail extract that effectively inhibits the phagocytosis of the keratinocyte activated by exposure to ultraviolet rays. Further, provided is a pharmaceutical composition which prevents and treats various kinds of diseases associated with phagocytosis. CONSTITUTION: A phagocytosis inhibiting composition is characterized by containing, as an active ingredient, Saururus Chinesis(Lour) Bail extract in the amount of 0.0001-10 wt.%. It is used for prevention and treatment of phagocytosis related diseases.
Abstract:
본 발명은 세포가 받고 있는 전단응력과 전기장을 독립적으로 제어하면서 다양한 외부 자극에 의한 세포의 반응을 실시간으로 관찰할 수 있는 미세유체 세포배양장치에 관한 것으로, 본 발명에 따르면, 균일한 전단응력을 가하기 위해 채널의 높이가 낮고 폭이 넓은 형태의 직사각형 단면을 가지는 세포 배양부, 상기 세포 배양부의 양단에 삽입되는 한천 염다리부(agar salt bridge), 실리콘 계열의 고분자 화합물로 덮은 후 경화시켜 유동액의 누수가 없도록 구성되어 채널 내부의 바닥에 삽입되는 전압 프로브(voltage probe)를 포함하고, 상기 실리콘 계열의 고분자 화합물이 전압 프로브의 피복의 역할과 동시에 세포가 자라는 기질(substrate)의 역할을 하며, 실리콘을 형성하는 조건을 변경하여 재질의 강성(rigidity)을 조절함으로써 세포가 자라는 생체 내 환경 � ��는 질병 상태를 모사할 수 있도록 구성된 전단응력과 전기장 및 바닥의 강성조절이 가능한 미세유체 세포배양장치가 제공된다.
Abstract:
The present invention relates to a microfluidic cell culture device capable of observing a reaction of cells caused by various external stimulations on a real time basis while independently controlling shearing stress and a magnetic field actuated on the cells. According to the present invention, the microfluidic cell culture device includes a cell culture unit having a rectangular cross section of a shape which the height of a channel is low and the width thereof is wide for applying uniform shearing stress; an agar salt bridge unit which are inserted into both end portions of the cell culture unit; and a voltage probe which is coated with a polymer compound of a silicon group and hardened to prevent a leakage of fluid and which is inserted into the inner bottom surface of the channel. The polymer compound of a silicon group functions as cladding for the voltage probe and a substrate on which the cells are cultured at the same time. The present invention provides the microfluidic cell culture device capable of controlling shearing stress, the magnetic field, and the rigidity of the substrate which enables an environment of a body where the cells are cultured by controlling the rigidity of a material or disease by changing conditions for forming silicon.
Abstract:
박테리아의 주화성 분석용 마이크로 플루이딕 장치, 제조방법 및 이를 이용한 박테리아의 주화성 분석 방법을 개시한다. 상기 박테리아의 주화성 분석용 마이크로 플루이딕 장치는 외부로부터 제공되는 유리 하부기판; 상기 유리 하부기판 상에 접하되도록 형성되는 PDMS 상부 기판;을 포함하며, 상부 기판은, 다종의 세포를 배양시키는 적어도 하나 이상의 세포 배양 챔버; 상기 PDMS 상부 기판 내에 형성되며, 외부로부터 제공되는 박테리아를 상기 상부 기판 내에 주입시키도록 형성된 박테리아 주입구; 외부로부터 제공되는 콜라겐 젤이 주입되는 적어도 한 개 이상의 콜라겐 젤 주입구;를 포함하며, 상기 PDMS 상부 기판은, 상기 세포 배양 챔버, 박테리아 주입 채널 입구, 박테리아 추출 채널 출구 및 콜라겐 젤 주입구가 연결시키는 미세 유로들가 형성되는 것을 특징으로 한다.